跳至主要内容
临床试验/NCT06174298
NCT06174298招募中4 期

The Role of Granulocyte Colony Stimulating Factor in Embryo Transfer Outcomes

Newlife Fertility Centre1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年3月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
300
试验地点
1
主要终点
Clinical Pregnancy Rate

研究概览

简要总结

The goal of this clinical trial is to test the effect of granulocyte colony-stimulating factor (G-CSF, A.K.A. Filgrastim) in infertility patients undergoing in vitro fertilization (IVF) treatment. The main question it aims to answer is:

Can in vitro fertilization-embryo transfer (IVF-ET) outcomes be improved by supplementing the transfer media with Granulocyte colony-stimulating factor (GCSF)?

Participants will undergo their embryo transfer as per the normal clinic protocol but will be randomized to either receive the standard embryo transfer media or the GCSG-supplemented transfer media.

Researchers will compare the GCSF and standard transfer media groups to see if clinical outcomes are improved (i.e., implantation rate, pregnancy, clinical pregnancy rate, live birth rate).

详细描述

Please see uploaded study protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 38 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Recruited subjects will either be undergoing a fresh IVF-ET cycle in which the embryo(s) generated from the initial treatment cycle are transferred during that same cycle (i.e., on day 5 or 6 post-egg retrieval) or an FET cycle in which the embryo(s) transferred were generated in a previous IVF cycle and were cryopreserved for subsequent warming and transfer.

排除标准

  • Patients with uterine factor or severe male factor infertility will be excluded.
  • Patients who have had previous IVF failures will be excluded.

研究组 & 干预措施

GCSF-Supplemented Embryo Transfer Media

Experimental

Intervention Group Frozen Embryo Transfers: Cryopreserved embryos will be thawed according to the Kitazato thawing protocol and will be subsequently transferred to a center-well dish containing 1 mL of embryo transfer media supplemented with GCSF. The embryos will be cultured in this medium for approximately 3 hours before the embryo transfer (ET) procedure. During the ET procedure, the same media will be used to fill the ET syringe and catheter that will be used to deposit the embryos into the uterus by the physician.

Fresh Embryo Transfers: On day 5 or 6 of culture, viable embryos will be transferred into a center-well dish containing 1 mL of embryo transfer media supplemented with GCSF. The embryos will be cultured in this medium for approximately 3 hours before the ET procedure. During the ET procedure, the same media will be used to fill the ET syringe and catheter that will be used to deposit the embryos into the uterus by the physician.

干预措施: Granulocyte Colony-Stimulating Factor (Filgrastim) (Drug)

Standard Embryo Transfer Media

Placebo Comparator

Control Group Fresh Embryo Transfers: On day 5 or 6 of culture, viable embryos will be transferred into a center-well dish containing 1 mL of standard embryo transfer media. The embryos will be cultured in this medium for approximately 3 hours before the embryo transfer (ET) procedure. During the ET procedure, the same media will be used to fill the ET syringe and catheter that will be used to deposit the embryos into the uterus by the physician.

Control Group Frozen Embryo Transfers: Cryopreserved embryos will be thawed according to the Kitazato thawing protocol and will be subsequently transferred to a center-well dish containing 1 mL of standard embryo transfer media. The embryos will be cultured in this medium for approximately 3 hours before the ET procedure. During the ET procedure, the same media will be used to fill the ET syringe and catheter that will be used to deposit the embryos into the uterus by the physician.

干预措施: Standard Embryo Transfer Media (Other)

结局指标

主要结局

Clinical Pregnancy Rate

时间窗: From enrollment to the time of 6-week ultrasound.

Number of patients with fetal heartbeats detected at time of 6-week ultrasound divided by the total number of patients in that group.

Implantation Rate

时间窗: From enrollment to the time of 6-week ultrasound.

Number of embryos implanted (i.e. number of gestational sacs observed under ultrasound guidance) divided by total number of embryos transferred

Pregnancy Rate

时间窗: From enrollment to the time of blood test at 10 days post-ET.

Number of patients with a positive beta-human chorionic gonadotropin (bhCG) pregnancy blood test at 10 days post-ET divided by the total number of patients in that group.

Live Birth Rate

时间窗: From enrollment to the time of birth (up to 9-months post-ET).

Total Number of infants born divided by the total number of embryo transfers performed (i.e., patients) in that group.

次要结局

  • Spontaneous Abortion Rate(From enrollment to the time of pregnancy loss (up to 20 weeks post-ET).)
  • Biochemical Pregnancy Rate(From enrollment to the time of 6-week ultrasound.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Role of Granulocyte Colony Stimulating Factor in... | 临床试验